SARS-CoV-2
Virus that causes COVID-19
SARS-CoV-2 ▸ Facts ▸ Comments ▸ News ▸ Videos
Severe acute respiratory syndrome coronavirus 2 (SARSāCoVā2) is a strain of coronavirus that causes COVID-19, the respiratory illness responsible for the COVID-19 pandemic. The virus previously had the provisional name 2019 novel coronavirus (2019-nCoV), and has also been called human coronavirus 2019. First identified in the city of Wuhan, Hubei, China, the World Health Organization designated the outbreak a public health emergency of international concern from January 30, 2020, to May 5, 2023. SARSāCoVā2 is a positive-sense single-stranded RNA virus that is contagious in humans.
| 0 shares | ShareTweetSavePostSend |
You Might Like
'Virus has reemerged..' Experts warn India to be prepared for another COVID outbreak, this variant is...The latest update from the World Health Organization (WHO) showed that between June 24 and July 21, an average of 17,358 Covid specimens were tested for SARS-CoV-2 every week across 85 countries.DNA - Published | |
Scientists in Bengaluru discover means to tackle Covid-19 variantsScientists discovered a way to fight current and future variants of SARS-CoV2 by boosting the body's antiviral defenses. They focused on enhancing antimicrobial peptides (AMPs) and found that higher..IndiaTimes - Published | |
All Covid strains given to Bharat Biotech for a universal jab: CentreIndian Council of Medical Research (ICMR) has transferred all existing strains of variants of concern of SARS-CoV-2 - virus that causes Covid-19 - to Bharat Biotech Ltd for developing a universal Covid..IndiaTimes - Published | |
Indian scientists uncover hidden reservoir of SARS-CoV-2 in body cells, paving way for improved Covid-19 diagnosisIndiaTimes - Published | |
This flu season, H3N2 trumps swine flu, CovidIn the battleground of viruses, a clear dominator this monsoon has been the influenza A subtype H3N2 that has surpassed two recent pandemic viruses, H1N1 (swine flu) and SARS-CoV-2. Co-circulating with..IndiaTimes - Published | |
Evidence of viral resistance to Covid-19 drug Paxlovid foundA new research provided evidence of viral resistance to Paxlovid among SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug could soon become less effective in..IndiaTimes - Published | |
Enhanced recombination is a shot in the arm for SARS-CoV-2: IISc studyIndiaTimes - Published | |
āIndia detected 300 Omicron sub-lineages, none settledāBetween December 24 and January 3, the health ministry sources said, 124 people arriving to India from abroad were found positive for Covid-19. The sources said 11 variants of SARS-CoV-2 were..IndiaTimes - Published | |
Covid positivity at 0.1% in last 24 hours: GovtThe sources said 11 variants of SARS-CoV-2, the virus that causes Covid-19, were identified in Whole Genome Sequencing (WSG) carried out on the samples of 40 passengers who were found positive.IndiaTimes - Published | |
India-made drug shows promise in treating Covid heart damageA drug developed by the Defence Research and Development Organisation (DRDO) may reverse the heart damage caused by a protein in the SARS-CoV-2 virus, a study conducted in fruit flies and mice has..IndiaTimes - Published | |
Main Omicron subvariant now mutating further: InsacogBA.2.75 has spawned what has been designated as BA.2.75.2, which recently drew the attention of experts tracking mutations in SARS-CoV-2. Yunlong Richard Cao, an immunologist at Peking University,..IndiaTimes - Published | |
BA.2.38 causing just mild illness: StudyOmicron sub-variant BA.2's offspring, BA.2.38, may be causing a spike in Maharashtra and other parts of India, but the illness it is causing is self-limiting and almost comparable with common cold-like..IndiaTimes - Published | |
Anocovax: India's first Covid vaccine for animals launchedThe immunity induced by Anocovax neutralises both Delta and Omicron variants of SARS-CoV-2, the Indian Council of Agricultural Research (ICAR) said.DNA - Published | Are 3 doses of Covid-19 vaccine better than 2? Study says THISDuring study period, 197,535 (6.3 per cent) patients were infected with SARS-CoV-2, and of those, 15,786 (8 per cent) were admitted to the hospital.DNA - Published |
Omicron now dominant variant of SARS-CoV-2 in country: GovernmentIndiaTimes - Published | PM Modi to hold meeting today in wake of Omicron threatWith Omicron cases growing rapidly in the country, PM Narendra Modi has called for a high level meeting on Thursday to review Covid-19 situation.A total of 213 cases infected with Omicron variant of..IndiaTimes - Published |
Bharat Biotech seeks DCGI nod for phase-3 study of intra-nasal Covid vaccine as booster dose"Bharat Biotech has put in an application seeking permission to conduct a study titled 'A Phase 3 Study to Evaluate the Safety and Immunogenicity of BBV154 and BBV152 as third dose (booster) to..IndiaTimes - Published | Covid-19: FAQs on SARS-CoV-2 variant OmicronIndiaTimes - Published |
Omicron variant does not escape RT-PCR and RAT, Centre tells states as it asks them to ramp up testingUnderlining that the Omicron variant of SARS-CoV-2 does not escape RT-PCR and RAT tests, the Centre advised states and UTs on Tuesday to ramp up testing for early identification of any cases, undertake..IndiaTimes - Published | Expert panel mulls nod to āadditional doseā of Covid vaccine to elderlyAmid mounting fear over the new SARS-COV2 variant Omicron, an expert committee on Covid immunisation is considering to recommend an āadditional doseā to those who are immunocompromised or are..IndiaTimes - Published |
In view of new Covid variant, govt lists measures to be followed by states/UTsIn view of the possible threat that Omicron - the SARS-CoV2 variant of concern - can pose to the country, the Centre advised states and UTs to immediately focus on intensive containment, active..IndiaTimes - Published | Covaxin well tolerated, phase 3 data shows 77.8% efficacy against symptomatic Covid: LancetJust a week after the World Health Organisation (WHO) granted Emergency Use Listing (EUL) to Covaxin, prestigious medical journal Lancet has stated that phase 3 data of the vaccine demonstrates 77.8%..IndiaTimes - Published |
Covid-19: Policy on booster shot soon, says panel memberDr NK Arora, co-chair of INSACOG, a 28-lab consortium set up to monitor genomic variations in SARS-CoV-2, urged people not to take a booster dose right now as it wonāt be considered for any..IndiaTimes - Published | |
